Immuron (IMRN) Change in Receivables (2016 - 2023)
Immuron's (IMRN) quarterly Change in Receivables came in at $2.2 million in Q4 2023, up 281.59% year-on-year from $583772.0 in Q4 2022, and up 281.59% quarter-over-quarter from $583772.0 in Q4 2022.
Immuron (IMRN) Change in Receivables (2016 - 2023) Analysis & Trends
Immuron's Change in Receivables history runs 7 years deep, the most recent figure standing at $2.2 million for Q4 2023.
- On a quarterly basis, Change in Receivables rose 281.59% year-over-year to $2.2 million in Q4 2023; TTM through Dec 2023 was $2.6 million, a 231.59% increase from a year earlier, with the FY2025 full-year figure at $361172.0, down 42.54% from the prior year.
- Change in Receivables improved to $2.2 million in Q4 2023 per IMRN's latest filing, from $583772.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q4 2023 and bottomed at -$241381.0 in Q2 2022.
- The 5-year median for Change in Receivables is $502025.7 (2020), against an average of $614727.0.
- Across the five-year window, Change in Receivables tumbled 1460.68% in 2022 and soared 281.59% in 2023, its largest moves.
- Year by year, Change in Receivables stood at $680337.0 in 2019, then plunged by 38.22% to $420279.3 in 2020, then sank by 95.78% to $17739.8 in 2021, then soared by 3190.75% to $583772.0 in 2022, then surged by 281.59% to $2.2 million in 2023.
- Per Business Quant, the three latest IMRN Change in Receivables figures stand at $2.2 million (Q4 2023), $583772.0 (Q4 2022), and -$241381.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 583,772.00 |
| Dec 31, 2022 | 583,772.00 |
| Jun 30, 2022 | -241,380.99 |
| Jun 30, 2022 | -241,380.99 |
| Jun 30, 2021 | 17,739.76 |
| Jun 30, 2021 | 17,739.76 |
| Jun 30, 2020 | 420,279.30 |
| Jun 30, 2020 | 420,279.30 |
| Dec 31, 2019 | 680,337.00 |
| Dec 31, 2019 | 680,337.00 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2016 | 501,319.99 |
| Dec 31, 2016 | 501,319.99 |